Hospitals and pharmacies around the country are facing severe shortages of essential drugs. These shortages can limit access to critical medications and compromise patient safety, resulting in serious illness and even death. ...
Dec 11, 2014
0
0
A Spanish researcher has collaborated on a mathematical analysis, recently published in the journal Science Translational Medicine, which concludes that joint therapy to counter HIV in patients who also have hepatitis C increases ...
Dec 3, 2014
0
0
U.S. regulators have declined to approve Bristol-Myers Squibb's daclatasvir as part of a combination hepatitis C treatment with another antiviral drug called asunaprevir.
Nov 26, 2014
0
0
Global aid agency Doctors Without Borders said on Thursday it would begin unprecedented trials on patients in west Africa to test Ebola drugs and the use of survivors' blood as therapy.
Nov 13, 2014
0
0
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.
Sep 15, 2014
0
0
A mechanism that enables the development of resistance to Acute Myeloid Leukemia (AML) anticancer drugs, thereby leading to relapse, has been identified by Kathy Borden of the University of Montreal's Institute for Research ...
May 28, 2014
0
0
A study tracing the evolution of HIV in North America involving researchers at Simon Fraser University has found evidence that the virus is slowly adapting over time to its human hosts. However, this change is so gradual ...
Apr 24, 2014
0
0
(Medical Xpress)—Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially ...
Apr 10, 2014
0
0
Patients' risk of stroke significantly increased following the first signs of shingles, but antiviral drugs appeared to offer some protection, according to a new study in Clinical Infectious Diseases, now available online. ...
Apr 3, 2014
0
0
A commonly-used HIV drug has been shown to kill-off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial led by The University of Manchester with Kenyatta National Hospital (KNH) in ...
Feb 17, 2014
0
0
